![]() | Up a level |
Journal Article
Galldiks, Norbert ORCID: 0000-0002-2485-1796, Dunkl, Veronika, Stoffels, Gabriele
ORCID: 0000-0001-7114-1941, Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska
ORCID: 0000-0001-9093-8307, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter
ORCID: 0000-0003-3894-5053, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R.
ORCID: 0000-0002-8230-1856, Drzezga, Alexander, Schmidt, Matthias and Langen, Karl-Josef
ORCID: 0000-0003-1101-5075
(2015).
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[F-18]fluoroethyl)-L-tyrosine PET.
Eur. J. Nucl. Med. Mol. Imaging, 42 (5).
S. 685 - 696.
NEW YORK:
SPRINGER.
ISSN 1619-7089
Galldiks, Norbert ORCID: 0000-0002-2485-1796, Dunkl, Veronika, Stoffels, Gabriele
ORCID: 0000-0001-7114-1941, Hutterer, Markus, Rapp, Marion, Sabel, Michael, Reifenberger, Guido, Kebir, Sied, Dorn, Franziska
ORCID: 0000-0001-9093-8307, Blau, Tobias, Herrlinger, Ulrich, Hau, Peter
ORCID: 0000-0003-3894-5053, Ruge, Maximilian I., Kocher, Martin, Goldbrunner, Roland, Fink, Gereon R.
ORCID: 0000-0002-8230-1856, Drzezga, Alexander, Schmidt, Matthias and Langen, Karl-Josef
ORCID: 0000-0003-1101-5075
(2015).
Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[F-18]fluoroethyl)-L-tyrosine PET.
Eur. J. Nucl. Med. Mol. Imaging, 42 (5).
S. 685 - 696.
NEW YORK:
SPRINGER.
ISSN 1619-7089
Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Kohnen, Ralf, Urbach, Horst, Stummer, Walter and Glas, Martin (2014). QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS. Neuro-Oncology, 16. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Herrlinger, Ulrich, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter
ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Maciaczyk, Jaroslaw, Grau, Stefan, Schnell, Oliver, Haenel, Mathias, Krex, Dietmar, Vajkoczy, Peter, Gerlach, Ruediger, Kortmann, Rolf-Dieter, Mehdorn, Maximilian, Tuettenberg, Jochen, Mayer-Steinacker, Regine, Fietkau, Rainer, Brehmer, Stefanie, Mack, Frederic, Stuplich, Moritz, Kebir, Sied, Kohnen, Ralf, Dunkl, Elmar, Leutgeb, Barbara, Proescholdt, Martin, Pietsch, Torsten, Urbach, Horst, Belka, Claus, Stummer, Walter and Glas, Martin
(2016).
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial.
J. Clin. Oncol., 34 (14).
S. 1611 - 1623.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Herrlinger, Ulrich, Schaefer, Nildas, Steinbach, Joachim Peter, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Friedrich, Franziska, Rohde, Veit, Ringel, Florian, Braun, Christian, Kohnen, Ralf, Leutgeb, Barbara, Belka, Claus, Urbach, Horst, Stummer, Walter and Gies, Martin (2014). Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Herrlinger, Ulrich, Tzaridis, Theophilos, Mack, Frederic, Steinbach, Joachim, Schlegel, Uwe, Sabel, Michael, Hau, Peter, Kortman, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Tabatabai, Ghazaleh, Ringel, Florian, Schmidt-Graf, Friederike, Brehmer, Stefanie, Weyerbrock, Astrid, Bullinger, Lars, Vajkoczy, Peter, Vatter, Hartmut, Schaefer, Niklas, Kebir, Sied, Weller, Johannes, Stummer, Walter, Simon, Matthias, Keil, Vera ORCID: 0000-0001-8699-3506, Nelles, Michael, Fimmers, Rolf, Pietsch, Torsten, Hattingen, Elke, Coch, Christoph and Glas, Martin
(2017).
PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial.
Neuro-Oncology, 19.
S. 13 - 15.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866
Herrlinger, Ulrich, Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Sabel, Michael, Hau, Peter
ORCID: 0000-0003-3894-5053, Kortmann, Rolf-Dieter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Schnell, Oliver, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
ORCID: 0000-0002-3542-8782, Kowalski, Thomas, Ringel, Florian, Schmidt-Graf, Friederike, Suchorska, Bogdana, Brehmer, Stefanie, Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Renovanz, Miriam, Bullinger, Lars, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Vajkoczy, Peter, Misch, Martin, Vatter, Hartmut, Stuplich, Moritz, Schaefer, Niklas, Kebir, Sied, Weller, Johannes
ORCID: 0000-0001-5818-5392, Schaub, Christina, Stummer, Walter, Tonn, Joerg-Christian, Simon, Matthias, Keil, Vera C., Nelles, Michael, Urbach, Horst, Coenen, Martin, Wick, Wolfgang
ORCID: 0000-0002-6171-634X, Weller, Michael, Fimmers, Rolf, Schmid, Matthias
ORCID: 0000-0002-0788-0317, Hattingen, Elke
ORCID: 0000-0002-8392-9004, Pietsch, Torsten, Coch, Christoph and Glas, Martin
(2019).
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial.
Lancet, 393 (10172).
S. 678 - 689.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Hutterer, Markus, Bumes, Elisabeth, Riemenschneider, Markus J., Grosse, Jirka, Hellwig, Dirk ORCID: 0000-0002-3056-0143, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Langen, Karl-Josef
ORCID: 0000-0003-1101-5075 and Hau, Peter
ORCID: 0000-0003-3894-5053
(2017).
AIDS-Related Central Nervous System Toxoplasmosis With Increased 18F-Fluoroethyl-l-Tyrosine Amino Acid PET Uptake Due to LAT1/2 Expression of Inflammatory Cells.
Clin. Nucl. Med., 42 (12).
S. E506 - 3.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1536-0229
Hutterer, Markus, Ebner, Yvonne, Riemenschneider, Markus J., Willuweit, Antje ORCID: 0000-0002-6725-0755, McCoy, Mark, Egger, Barbara, Schroeder, Michael, Wendl, Christina, Hellwig, Dirk
ORCID: 0000-0002-3056-0143, Grosse, Jirka, Menhart, Karin, Proescholdt, Martin, Fritsch, Brita, Urbach, Horst, Stockhammer, Guenther, Roelcke, Ulrich, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Meyer, Philipp T., Langen, Karl-Josef
ORCID: 0000-0003-1101-5075, Hau, Peter
ORCID: 0000-0003-3894-5053 and Trinka, Eugen
(2017).
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by F-18-Fluoroethyl-L-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic.
J. Nucl. Med., 58 (1).
S. 129 - 138.
RESTON:
SOC NUCLEAR MEDICINE INC.
ISSN 1535-5667
Hutterer, Markus, Krenn, Yvonne, Kunz, Alexander, McCoy, Marc, Egger, Barbara, Schroeder, Michael, Wendl, Christina, Marienhagen, Joerg, Fritsch, Brita, Urbach, Horst, Meyer, Philipp T., Galldiks, Norbert ORCID: 0000-0002-2485-1796, Langen, Karl-Josef
ORCID: 0000-0003-1101-5075, Hau, Peter and Trinka, Eugen
(2014).
INCREASED CEREBRAL AMINO ACID UPTAKE DURING AND AFTER EPILEPTIC DISORDERS MIMICS BRAIN TUMOR IN F-18-FET PET.
Neuro-Oncology, 16.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866
Illerhaus, Gerald, Fritsch, Kristina, Egerer, Gerlinde, Lamprecht, Monika, von Bubnoff, Nikolas ORCID: 0000-0001-9593-8947, Wolf, Hans-Heinrich, Doelken, Gottfried, Stilgenbauer, Stephan, Panse, Jens, Balabanov, Stefan, Hau, Peter, Frickhofen, Norbert, Bentz, Martin, Roeth, Alexander, Moehle, Robert, Birnbaum, Tobias, Pfreundschuh, Michael, Hader, Claudia, Ihorst, Gabriele, Deckert, Martina, Prinz, Marco, Schorb, Elisabeth, Fricker, Heidi, Kasenda, Benjamin
ORCID: 0000-0003-0110-8585 and Finke, Juergen
(2012).
Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg.
Blood, 120 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 0006-4971
Illerhaus, Gerald, Kasenda, Benjamin ORCID: 0000-0003-0110-8585, Ihorst, Gabriele, Egerer, Gerlinde, Lamprecht, Monika, Keller, Ulrich, Wolf, Hans-Heinrich, Hirt, Carsten, Stilgenbauer, Stephan, Binder, Mascha
ORCID: 0000-0003-0663-3004, Hau, Peter
ORCID: 0000-0003-3894-5053, Edinger, Matthias
ORCID: 0000-0003-2889-2533, Frickhofen, Norbert, Bentz, Martin, Moehle, Robert, Roeth, Alexander, Pfreundschuh, Michael, von Baumgarten, Louisa, Deckert, Martina, Hader, Claudia, Fricker, Heidi, Valk, Elke, Schorb, Elisabeth, Fritsch, Kristina and Finke, Juergen
(2016).
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
Lancet Haematol., 3 (8).
S. E388 - 10.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2352-3026
Kebir, Sied, Hattingen, Elke, Schaub, Christina, Schafer, Niklas, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Tzaridis, Theophilos, Baehr, Oliver, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich (2016). EFFECT OF AGE ON OUTCOME IN THE GLARIUS TRIAL. Neuro-Oncology, 18. S. 5 - 6. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Kebir, Sied, Schaub, Christina, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Hau, Peter, Goldbrunner, Roland, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Weller, Johannes
ORCID: 0000-0001-5818-5392, Mack, Frederic, Tzaridis, Theophilos
ORCID: 0000-0001-9651-1144, Baehr, Oliver, Seidel, Clemens, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Borchers, Christian, Tabatabai, Ghazaleh
ORCID: 0000-0002-3542-8782, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Glas, Martin and Herrlinger, Ulrich
(2019).
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trial.
J. Neuro-Oncol., 144 (3).
S. 501 - 510.
NEW YORK:
SPRINGER.
ISSN 1573-7373
Kebir, Sied, Stummer, Walter, Steinbach, Joachim, Weyerbrock, Astrid, Hau, Peter, Goldbrunner, Roland, Proescholdt, Martin, Vatter, Hartmut, Herrlinger, Ulrich and Glas, Martin (2017). COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA: RESULTS FROM THE GLARIUS TRIAL. Neuro-Oncology, 19. S. 235 - 236. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Schaefer, Niklas, Proescholdt, Martin, Steinbach, Joachim P., Weyerbrock, Astrid ORCID: 0000-0001-9060-4462, Hau, Peter
ORCID: 0000-0003-3894-5053, Grauer, Oliver, Goldbrunner, Roland, Friedrich, Franziska, Rohde, veit, Ringel, Florian, Schlegel, Uwe, Sabel, Michael, Ronellenfitsch, Michael W., Uhl, Martin, Grau, Stefan, Haenel, Mathias, Schnell, Oliver, Krex, Dietmar, Vajkoczy, Peter, Tabatabai, Ghazaleh
ORCID: 0000-0002-3542-8782, Mack, Frederic, Schaub, Christina, Tzaridis, Theophilos
ORCID: 0000-0001-9651-1144, Niessen, Michael, Kebir, Sied, Leutgeb, Barbara, Urbach, Horst, Belka, Claus, Stummer, Walter, Glas, Martin and Herrlinger, Ulrich
(2018).
Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma.
Neuro-Oncology, 20 (7).
S. 975 - 986.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866
Schaub, Christina, Kebir, Sied, Junold, Nina, Hattingen, Elke ORCID: 0000-0002-8392-9004, Schaefer, Niklas, Steinbach, Joachim P., Weyerbrock, Astrid
ORCID: 0000-0001-9060-4462, Hau, Peter
ORCID: 0000-0003-3894-5053, Goldbrunner, Roland, Niessen, Michael, Mack, Frederic, Stuplich, Moritz, Tzaridis, Theophilos, Baehr, Oliver, Kortmann, Rolf-Dieter, Schlegel, Uwe, Schmidt-Graf, Friederike, Rohde, Veit, Braun, Christian, Haenel, Mathias, Sabel, Michael, Gerlach, Ruediger, Krex, Dietmar, Belka, Claus, Vatter, Hartmut, Proescholdt, Martin, Herrlinger, Ulrich and Glas, Martin
(2018).
Tumor growth patterns of MGMT-non-methylated glioblastoma in the randomized GLARIUS trial.
J. Cancer Res. Clin. Oncol., 144 (8).
S. 1581 - 1590.
NEW YORK:
SPRINGER.
ISSN 1432-1335
Schliesser, Maximilian Georg, Claus, Rainer ORCID: 0000-0003-2617-8766, Hielscher, Thomas, Grimm, Christiane, Weichenhan, Dieter, Blaes, Jonas, Wiestler, Benedikt, Hau, Peter
ORCID: 0000-0003-3894-5053, Schramm, Johannes, Sahm, Felix
ORCID: 0000-0001-5441-1962, Weiss, Elisa K., Weiler, Markus, Baer, Constance, Schmidt-Graf, Friederike, Schackert, Gabriele, Westphal, Manfred, Hertenstein, Anne, Roth, Patrick
ORCID: 0000-0003-3897-214X, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Hartmann, Christian, Pietsch, Torsten, Felsberg, Joerg, Reifenberger, Guido, Sabel, Michael Christoph, Winkler, Frank, von Deimling, Andreas
ORCID: 0000-0002-5863-540X, Meisner, Christoph, Vajkoczy, Peter, Platten, Michael
ORCID: 0000-0002-4746-887X, Weller, Michael
ORCID: 0000-0002-1748-174X, Plass, Christoph and Wick, Wolfgang
ORCID: 0000-0002-6171-634X
(2016).
Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Oncotarget, 7 (50).
S. 82028 - 82046.
ORCHARD PARK:
IMPACT JOURNALS LLC.
ISSN 1949-2553
Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Schaefer, Niklas, Weller, Johannes, Steinbach, Joachim-Peter, Schlegel, Uwe, Seidel, Sabine, Sabel, Michael, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Tonn, Joerg-Christian, Grauer, Oliver, Kebir, Sied, Schneider, Matthias, Schaub, Christina, Vatter, Hartmut, Coch, Christoph, Glas, Martin, Fimmers, Rolf, Pietsch, Torsten, Reifenberger, Guido, Herrlinger, Ulrich and Felsberg, Joerg
.
MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial.
Int. J. Cancer.
HOBOKEN:
WILEY.
ISSN 1097-0215
Tzaridis, Theophilos ORCID: 0000-0001-9651-1144, Weller, Johannes, Bachurski, Daniel
ORCID: 0000-0001-9168-9680, Shakeri, Farhad
ORCID: 0000-0003-1161-1942, Schaub, Christina, Hau, Peter, Buness, Andreas, Schlegel, Uwe, Steinbach, Joachim-Peter, Seidel, Clemens, Goldbrunner, Roland, Schaefer, Niklas, Wechsler-Reya, Robert J., Hallek, Michael
ORCID: 0000-0002-7425-4455, Scheffler, Bjoern, Glas, Martin, Haeberle, Lothar, Herrlinger, Ulrich, Coch, Christoph, Reiners, Katrin S. and Hartmann, Gunther
(2023).
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression.
Int. J. Cancer, 152 (2).
S. 308 - 320.
HOBOKEN:
WILEY.
ISSN 1097-0215
Weller, Johannes ORCID: 0000-0001-5818-5392, Schaefer, Niklas, Schaub, Christina, Potthoff, Anna-Laura, Steinbach, Joachim P., Schlegel, Uwe, Sabel, Michael
ORCID: 0009-0000-1485-7820, Hau, Peter, Seidel, Clemens, Krex, Dietmar, Goldbrunner, Roland, Pietsch, Torsten, Tzaridis, Theophilos, Zeyen, Thomas, Borger, Valeri, Guresir, Erdem, Vatter, Hartmut, Herrlinger, Ulrich and Schneider, Matthias
(2022).
Prognostic impact of obesity in newly-diagnosed glioblastoma: a secondary analysis of CeTeG/NOA-09 and GLARIUS.
J. Neuro-Oncol., 159 (1).
S. 95 - 102.
NEW YORK:
SPRINGER.
ISSN 1573-7373
Weller, Johannes ORCID: 0000-0001-5818-5392, Tzaridis, Theophilos
ORCID: 0000-0001-9651-1144, Mack, Frederic, Steinbach, Joachim Peter, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh
ORCID: 0000-0002-3542-8782, Brehmer, Stefanie, Bullinger, Lars, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Schaub, Christina, Kebir, Sied, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich and Schaefer, Niklas
(2019).
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol., 20 (10).
S. 1444 - 1454.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Weller, Johannes, Tzaridis, Theophilos, Steinbach, Joachim, Schlegel, Uwe, Hau, Peter, Krex, Dietmar, Grauer, Oliver, Goldbrunner, Roland, Baehr, Oliver, Uhl, Martin, Seidel, Clemens, Tabatabai, Ghazaleh, Bullinger, Lars, Galldiks, Norbert ORCID: 0000-0002-2485-1796, Schaub, Christina, Stummer, Walter, Simon, Matthias, Fimmers, Rolf, Matthias, Schmid, Coch, Christoph, Glas, Martin, Herrlinger, Ulrich and Schaefer, Niklas
(2018).
QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA.
Neuro-Oncology, 20.
S. 218 - 220.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866
Wick, Wolfgang ORCID: 0000-0002-6171-634X, Roth, Patrick, Hartmann, Christian, Hau, Peter
ORCID: 0000-0003-3894-5053, Nakamura, Makoto, Stockhammer, Florian
ORCID: 0000-0002-0525-5956, Sabel, Michael C., Wick, Antje, Koeppen, Susanne, Ketter, Ralf, Vajkoczy, Peter, Eyupoglu, Ilker, Kalff, Rolf, Pietsch, Torsten, Happold, Caroline, Galldiks, Norbert
ORCID: 0000-0002-2485-1796, Schmidt-Graf, Friederike, Bamberg, Michael, Reifenberger, Guido, Platten, Michael
ORCID: 0000-0002-4746-887X, von Deimling, Andreas
ORCID: 0000-0002-5863-540X, Meisner, Christoph, Wiestler, Benedikt and Weller, Michael
ORCID: 0000-0002-1748-174X
(2016).
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide.
Neuro-Oncology, 18 (11).
S. 1529 - 1538.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1523-5866
Zeyen, Thomas, Potthoff, Anna-Laura, Nemeth, Robert, Heiland, Dieter H., Burger, Michael C., Steinbach, Joachim P., Hau, Peter, Tabatabai, Ghazaleh, Glas, Martin, Schlegel, Uwe, Grauer, Oliver, Krex, Dietmar, Schnell, Oliver, Goldbrunner, Roland, Sabel, Michael ORCID: 0009-0000-1485-7820, Thon, Niklas, Delev, Daniel, Clusmann, Hans, Seidel, Clemens, Gueresir, Erdem, Schmid, Matthias
ORCID: 0000-0002-0788-0317, Schuss, Patrick
ORCID: 0000-0002-5806-2576, Giordano, Frank A., Radbruch, Alexander, Becker, Albert, Weller, Johannes, Schaub, Christina, Vatter, Hartmut, Schilling, Judith, Winkler, Frank
ORCID: 0000-0003-4892-6104, Herrlinger, Ulrich and Schneider, Matthias
(2022).
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
Trials, 23 (1).
LONDON:
BMC.
ISSN 1745-6215
de Castilhos, Juliana ORCID: 0000-0001-9966-8657, Zamir, Eli, Hippchen, Theresa, Rohrbach, Roman
ORCID: 0000-0003-3458-6620, Schmidt, Sabine, Hengler, Silvana, Schumacher, Hanna
ORCID: 0000-0003-2665-9236, Neubauer, Melanie, Kunz, Sabrina, Mueller-Esch, Tonia, Hiergeist, Andreas, Gessner, Andre, Khalid, Dina, Gaiser, Rogier, Cullin, Nyssa, Papagiannarou, Stamatia M., Beuthien-Baumann, Bettina, Kraemer, Alwin, Bartenschlager, Ralf, Jaeger, Dirk, Mueller, Michael, Herth, Felix, Duerschmied, Daniel, Schneider, Jochen, Schmid, Roland M., Eberhardt, Johann F., Khodamoradi, Yascha
ORCID: 0000-0001-5972-0967, Vehreschild, Maria J. G. T., Teufel, Andreas, Ebert, Matthias P., Hau, Peter, Salzberger, Bernd, Schnitzler, Paul, Poeck, Hendrik, Elinav, Eran, Merle, Uta and Stein-Thoeringer, Christoph K.
(2022).
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
Clin. Infect. Dis., 75 (1).
S. E1063 - 9.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1537-6591
de Castilhos, Juliana, Zamir, Eli, Hippchen, Theresa, Rohrbach, Roman, Schmidt, Sabine, Hengler, Silvana, Schumacher, Hanna, Neubauer, Melanie, Kunz, Sabrina, Mueller-Esch, Tonia, Hiergeist, Andreas, Gessner, Andre, Khalid, Dina, Gaiser, Rogier, Cullin, Nyssa, Papagiannarou, Stamatia M., Beuthien-Baumann, Bettina, Kraemer, Alwin, Bartenschlager, Ralf, Jaeger, Dirk, Mueller, Michael, Herth, Felix, Duerschmied, Daniel, Schneider, Jochen ORCID: 0000-0002-0300-0159, Schmid, Roland M., Eberhardt, Johann F., Khodamoradi, Yascha, Vehreschild, Maria J. G. T., Teufel, Andreas, Ebert, Matthias P., Hau, Peter, Salzberger, Bernd, Schnitzler, Paul, Poeck, Hendrik, Elinav, Eran, Merle, Uta and Stein-Thoeringer, Christoph K.
(2022).
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients (ciab902, 2021).
Clin. Infect. Dis., 75 (1).
S. 185 - 186.
CARY:
OXFORD UNIV PRESS INC.
ISSN 1537-6591